Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-20-017400

Options or other derivatives

  • Chief Operating Officer acquired 226,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Discordia Robert Paul · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-06 Grant or award : show line 1 in the form Stock Option(right to buy) +226,000 $4.53 2030-03-06 226,000 226,000 D
Loading xslF345X03/doc4.xml…